QUIT — Achieve Life Sciences Share News
0.000.00%
Last trade - 00:00- $746.03m
- $573.64m
Some US drug developers jump after FDA announces recipients of national priority vouchers
Revolution, Achieve, Disc Medicine rise after FDA unveils fast-track review list
Brief: Achieve Life Sciences Receives FDA Commissioner's National Priority Voucher For Cytisinicline For Treatment Of Nicotine Dependence For E-Cigarette Or Vaping Cessation
Brief: Achieve Promotes Jason Yee To Chief Financial Officer
Brief: Achieve Life Sciences Promotes Craig Donnelly To Chief Operations Officer
Brief: Achieve Life Sciences Names Dr. Mark Rubinstein Interim Chief Medical Officer
Brief: Achieve Life Sciences Announces FDA Acceptance Of Cytisinicline New Drug Application For Treatment Of Nicotine Dependence For Smoking Cessation
Achieve Life Sciences Inc reports results for the quarter ended June 30 - Earnings Summary
Achieve Life Sciences Q2 loss per share misses estimates
Achieve Life Sciences Inc expected to post a loss of 36 cents a share - Earnings Preview
Advisory: Alert incorrectly tagged to Achieve Life Sciences withdrawn
U.S. STOCKS ON THE MOVE-Estee Lauder, TC Energy, Cancer test makers
U.S. STOCKS ON THE MOVE- Nuclear stocks, Kymera Therapeutics, Estee Lauder
Achieve Life Sciences slides on $45 mln equity raise
Brief: Achieve Life Sciences Announces Pricing Of $45.0 Mln Underwritten Public Offering
Brief: Achieve Life Sciences Announces Proposed Underwritten Public Offering
Brief: Achieve Life Sciences Announces Partnership With Omnicom To Execute Integrated, Data-Driven Launch Of First Potential New Treatment For Nicotine Dependence In Nearly Two Decades
Brief: Achieve Life Sciences Announces Submission Of NDA To FDA For Cytisinicline As Treatment Of Nicotine Dependence For Smoking Cessation
Achieve Life Sciences drops on equity raise plans